Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Harvard Business School
Colorcon
Moodys
Mallinckrodt

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Details for Patent: 8,088,934


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,088,934 protect, and when does it expire?

Patent 8,088,934 protects AMITIZA and is included in one NDA.

This patent has forty-five patent family members in twenty-four countries.

Summary for Patent: 8,088,934
Title:Composition and method for stabilizing the same
Abstract: Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.
Inventor(s): Ueno; Ryuji (Montgomery, MD), Habe; Tsuyoshi (Sasayama, JP)
Assignee: SUCAMPO AG (Zurich, CH)
Application Number:12/144,000
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,088,934
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 8,088,934

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sucampo Pharma Llc AMITIZA lubiprostone CAPSULE;ORAL 021908-002 Apr 29, 2008 AB RX Yes No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Sucampo Pharma Llc AMITIZA lubiprostone CAPSULE;ORAL 021908-001 Jan 31, 2006 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,088,934

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 026046 ⤷  Try it Free
Argentina 089848 ⤷  Try it Free
Argentina 109354 ⤷  Try it Free
Austria 267189 ⤷  Try it Free
Austria 402925 ⤷  Try it Free
Australia 2004242503 ⤷  Try it Free
Australia 7685600 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Boehringer Ingelheim
Colorcon
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.